Table 1. Contrast agent application protocols (group 1–4) for acquisition of gadoxetate disodium-enhanced MR images and characteristics of patients included in each group.

Protocol No.	Injection rate	Contrast dose	BMI	Nasal oxygen	Number of patients	Sex	Age	MRI indication
1	2 ml/sec	0.025 mmol/kg (= 0.1ml/kg)	27 (16–42)	no	50	male = 40 female = 10	mean 52y (26-75y)	Cirrhosis (n = 12) PSC (n = 16) Tumor (n = 17) Other n = (5)
2	2 ml/sec	fixed 10 ml	24 (16–35)	no	50	male = 29 female = 21	mean 50y (19-84y)	Cirrhosis (n = 10) PSC (n = 23) Tumor (n = 11) Other (n = 6)
3	1 ml/sec	0.025 mmol/kg (= 0.1ml/kg)	27 (19–45)	no	50	male = 30 female = 20	mean 50y (19-73y)	Cirrhosis (n = 10) PSC (n = 11) Tumor (n = 20) Other (n = 9)
4	1ml /sec	0.025 mmol/kg (= 0.1ml/kg)	26 (16–46)	yes	50	male = 30 female = 20	mean 52y (18-79y)	Cirrhosis (n = 11) PSC (n = 11) Tumor (n = 19) Other (n = 9)

BMI = body mass index (mean, range in brackets); PSC = primary sclerosing cholangitis